Live daily coverage beginning June 1 from the ASCO meeting in Chicago.
The editorial teams in the Modern Medicine Primary Care Content Group, with content from our legacy brands - Medical Economics, Drug Topics, Geriatrics, Formulary and Contemporary OB/Gyn - will cover key medical meetings, bringing you breaking news, the latest research findings and reports from the general sessions.
Daily coverage from this year's American Society of Clinical Oncology (ASCO), begins now through June 3.
FDA and EMA Accepts Applications for New Nusinersen Regimen
January 23rd 2025An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines Agency (EMA) considerate it as an alternative than the current lower FDA-approved dosage.
Read More